1-7 of 7
Authors: Masahiro Yoshida
Sort by
Journal Article
Effectiveness of doxorubicin-based and liposomal doxorubicin chemotherapies for patients with extra-abdominal desmoid-type fibromatosis: a systematic review
Koki Shimizu and others
Japanese Journal of Clinical Oncology, Volume 50, Issue 11, November 2020, Pages 1274–1281, https://doi.org/10.1093/jjco/hyaa125
Published: 23 July 2020
Journal Article
Is tumour location a prognostic factor for pharmacological treatment in patients with desmoid-type fibromatosis? a systematic review
Hiroshi Koike and others
Japanese Journal of Clinical Oncology, Volume 50, Issue 9, September 2020, Pages 1032–1036, https://doi.org/10.1093/jjco/hyaa078
Published: 13 June 2020
Journal Article
Is mutation analysis of β-catenin useful for the diagnosis of desmoid-type fibromatosis? A systematic review
Tomohisa Sakai and others
Japanese Journal of Clinical Oncology, Volume 50, Issue 9, September 2020, Pages 1037–1042, https://doi.org/10.1093/jjco/hyaa080
Published: 13 June 2020
Journal Article
Usefulness of surgical treatment for asymptomatic patients with extra-peritoneal desmoid-type fibromatosis: a systematic review and meta-analysis
Get access
Munehisa Kito and others
Japanese Journal of Clinical Oncology, Volume 50, Issue 5, May 2020, Pages 574–580, https://doi.org/10.1093/jjco/hyaa009
Published: 02 March 2020
Journal Article
Definitive radiation therapy in patients with unresectable desmoid tumors: a systematic review
Get access
Tomoya Matsunobu and others
Japanese Journal of Clinical Oncology, Volume 50, Issue 5, May 2020, Pages 568–573, https://doi.org/10.1093/jjco/hyaa007
Published: 02 March 2020
Journal Article
Efficacy of low-dose chemotherapy with methotrexate and vinblastine for patients with extra-abdominal desmoid-type fibromatosis: a systematic review
Get access
Koki Shimizu and others
Japanese Journal of Clinical Oncology, Volume 50, Issue 4, April 2020, Pages 419–424, https://doi.org/10.1093/jjco/hyz204
Published: 17 December 2019
Journal Article
Diffuse Alveolar Hemorrhage as a Fatal Adverse Effect of Bevacizumab: An Autopsy Case
Get access
Satoshi Ikeda and others
Japanese Journal of Clinical Oncology, Volume 44, Issue 5, May 2014, Pages 497–500, https://doi.org/10.1093/jjco/hyu023
Published: 28 March 2014
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals